A drug with the SMILES CCN(CC)CCN1C(=O)C(=O)/C(=C(/O)c2ccc(S(=O)(=O)N3CCOCC3)cc2)C1c1ccc(C(C)C)cc1 has a human ether-à-go-go related gene (hERG) inhibition at 10uM of 11.916%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
CCN(CC)CCN1C(=O)C(=O)/C(=C(/O)c2ccc(S(=O)(=O)N3CCOCC3)cc2)C1c1ccc(C(C)C)cc1
CCN(CC)CCN1C(=O)C(=O)/C(=C(/O)c2ccc(S(=O)(=O)N3CCOCC3)cc2)C1c1ccc(C(C)C)cc1
(4E)-1-[2-(diethylamino)ethyl]-4-[hydroxy-(4-morpholin-4-ylsulfonylphenyl)methylidene]-5-(4-propan-2-ylphenyl)pyrrolidine-2,3-dione